These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20671103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
    le Poole CY, van Ittersum FJ, Valentijn RM, Teerlink T, Lindholm B, Ter Wee PM, Schalkwijk CG.
    Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
    [Abstract] [Full Text] [Related]

  • 4. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
    Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J, Euro Balance Trial Group.
    Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
    [Abstract] [Full Text] [Related]

  • 5. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T, Horie K, Ueda Y, Fujita Y, Izuhara Y, Hirano H, Uchida K, Saito A, van Ypersele de Strihou C, Kurokawa K.
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [Abstract] [Full Text] [Related]

  • 6. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
    Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F.
    J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
    [Abstract] [Full Text] [Related]

  • 7. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E.
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [Abstract] [Full Text] [Related]

  • 8. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B, Schmitt CP, Almeida M, Arbeiter K, Ardissino G, Bonzel KE, Edefonti A, Fischbach M, Haluany K, Misselwitz J, Kemper MJ, Rönnholm K, Wygoda S, Schaefer F, European Pediatric Peritoneal Dialysis Study Group.
    BMC Nephrol; 2004 Oct 14; 5():14. PubMed ID: 15485574
    [Abstract] [Full Text] [Related]

  • 9. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS.
    Kidney Int; 2004 Sep 14; 66(3):1257-65. PubMed ID: 15327425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M, Keuning ED, ter Wee PM, Schalkwijk CG, Beelen RH, van den Born J.
    Nephrol Dial Transplant; 2006 Jan 14; 21(1):208-16. PubMed ID: 16263741
    [Abstract] [Full Text] [Related]

  • 13. Effect of the dialysis fluid buffer on peritoneal membrane function in children.
    Schmitt CP, Nau B, Gemulla G, Bonzel KE, Hölttä T, Testa S, Fischbach M, John U, Kemper MJ, Sander A, Arbeiter K, Schaefer F.
    Clin J Am Soc Nephrol; 2013 Jan 14; 8(1):108-15. PubMed ID: 23124784
    [Abstract] [Full Text] [Related]

  • 14. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A, Plail M, Grabensee B, Plum J.
    Nephrol Dial Transplant; 2004 Aug 14; 19(8):2101-6. PubMed ID: 15213322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH, Do JY, Kim YH, Lee HY, Kim BS, Shin SK, Kim HC, Chang YK, Yang JO, Chung HC, Kim CD, Lee WK, Kim JY, Kim YL.
    Nephrol Dial Transplant; 2012 Mar 14; 27(3):1191-9. PubMed ID: 21862454
    [Abstract] [Full Text] [Related]

  • 17. Free L-Lysine and Its Methyl Ester React with Glyoxal and Methylglyoxal in Phosphate Buffer (100 mM, pH 7.4) to Form Nε-Carboxymethyl-Lysine, Nε-Carboxyethyl-Lysine and Nε-Hydroxymethyl-Lysine.
    Baskal S, Tsikas D.
    Int J Mol Sci; 2022 Mar 22; 23(7):. PubMed ID: 35408807
    [Abstract] [Full Text] [Related]

  • 18. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ.
    Cochrane Database Syst Rev; 2014 Mar 27; (3):CD007554. PubMed ID: 24671928
    [Abstract] [Full Text] [Related]

  • 19. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH, Lee EG, Kim IS, Kim YJ, Cho DK, Kim YL.
    Perit Dial Int; 2004 Mar 27; 24(2):115-22. PubMed ID: 15119632
    [Abstract] [Full Text] [Related]

  • 20. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
    Teerlink T, Barto R, Ten Brink HJ, Schalkwijk CG.
    Clin Chem; 2004 Jul 27; 50(7):1222-8. PubMed ID: 15131022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.